CompoSecure (NASDAQ:CMPO) Price Target Raised to $23.00

CompoSecure (NASDAQ:CMPO) had its price target boosted by B. Riley from $18.00 to $23.00 in a research report released on Monday,Benzinga reports. The firm currently has a buy rating on the stock. B. Riley also issued estimates for CompoSecure’s Q4 2024 earnings at $0.24 EPS, FY2024 earnings at $1.03 EPS and FY2025 earnings at $1.08 EPS.

Several other analysts have also weighed in on the stock. Lake Street Capital lifted their price objective on shares of CompoSecure from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, October 2nd. Compass Point increased their price objective on shares of CompoSecure from $11.50 to $14.50 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $16.00 target price on shares of CompoSecure in a research report on Monday. JPMorgan Chase & Co. increased their price target on CompoSecure from $8.00 to $12.00 and gave the stock a “neutral” rating in a report on Tuesday, August 20th. Finally, Benchmark boosted their price objective on CompoSecure from $12.00 to $17.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, CompoSecure currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.79.

CompoSecure Stock Performance

CMPO stock opened at $13.73 on Monday. The company’s fifty day simple moving average is $13.98 and its 200 day simple moving average is $10.03. CompoSecure has a 12-month low of $4.61 and a 12-month high of $16.14.

CompoSecure (NASDAQ:CMPO) last announced its quarterly earnings data on Friday, November 8th. The company reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.02). The business had revenue of $107.14 million during the quarter, compared to analyst estimates of $105.11 million. CompoSecure had a negative net margin of 5.63% and a negative return on equity of 14.87%. During the same period in the prior year, the firm earned $0.24 earnings per share. Sell-side analysts expect that CompoSecure will post 1.02 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Adam Joseph Lowe sold 5,730 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $12.05, for a total value of $69,046.50. Following the transaction, the insider now owns 1,292,219 shares in the company, valued at $15,571,238.95. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Jonathan Wilk sold 618,014 shares of the company’s stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $7.55, for a total value of $4,666,005.70. Following the completion of the sale, the chief executive officer now owns 618,013 shares in the company, valued at $4,665,998.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Adam Joseph Lowe sold 5,730 shares of the firm’s stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $12.05, for a total transaction of $69,046.50. Following the transaction, the insider now directly owns 1,292,219 shares in the company, valued at $15,571,238.95. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,641,727 shares of company stock valued at $80,370,824. Corporate insiders own 74.99% of the company’s stock.

Institutional Investors Weigh In On CompoSecure

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC grew its holdings in shares of CompoSecure by 1.7% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 40,944 shares of the company’s stock valued at $574,000 after acquiring an additional 701 shares in the last quarter. CWM LLC boosted its position in CompoSecure by 42.0% in the third quarter. CWM LLC now owns 5,192 shares of the company’s stock worth $73,000 after purchasing an additional 1,536 shares during the last quarter. Bard Associates Inc. grew its stake in CompoSecure by 0.6% in the 3rd quarter. Bard Associates Inc. now owns 305,247 shares of the company’s stock valued at $4,280,000 after purchasing an additional 1,957 shares during the period. Rhumbline Advisers increased its position in shares of CompoSecure by 17.3% during the 2nd quarter. Rhumbline Advisers now owns 19,521 shares of the company’s stock valued at $133,000 after purchasing an additional 2,877 shares during the last quarter. Finally, nVerses Capital LLC bought a new stake in shares of CompoSecure during the 3rd quarter worth $72,000. Hedge funds and other institutional investors own 37.56% of the company’s stock.

CompoSecure Company Profile

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.